Evidence map›Paper›PMID 34103632›Full record

ArticleScientific reports2021

Study of the relationship between applied transmembrane pressure and antimicrobial activity of lysozyme.

Simona M Miron, Ariane de Espindola, Patrick Dutournié, Arnaud Ponche

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Simona M MironInstitut de Science Des Matériaux de Mulhouse, Université de Haute-Alsace, CNRS IS2M UMR 7361, 3 bis rue A. Werner, 68098, Mulhouse Cedex, France.
Ariane de EspindolaInstitut de Science Des Matériaux de Mulhouse, Université de Haute-Alsace, CNRS IS2M UMR 7361, 3 bis rue A. Werner, 68098, Mulhouse Cedex, France.
Patrick DutourniéInstitut de Science Des Matériaux de Mulhouse, Université de Haute-Alsace, CNRS IS2M UMR 7361, 3 bis rue A. Werner, 68098, Mulhouse Cedex, France. patrick.dutournie@uha.fr.ORCID 0000-0002-3962-3761
Arnaud PoncheInstitut de Science Des Matériaux de Mulhouse, Université de Haute-Alsace, CNRS IS2M UMR 7361, 3 bis rue A. Werner, 68098, Mulhouse Cedex, France.
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the processing of biomolecules by ultrafiltration, the lysozyme enzyme undergoes conformational changes, which can affect its antibacterial activity. Operational conditions are considered to be one of the main parameters responsible for such changes, especially when using the same membrane and molecule. The present study demonstrates that, the same cut-off membrane (commercial data) can result in different properties of the protein after filtration, due to their different pore network. The filtration of lysozyme, regardless of the membrane, produces a decrease in the membrane hydraulic permeability (between 10 and 30%) and an increase in its selectivity in terms of observed rejection rate (30%). For the filtrated lysozyme, it appears that the HPLC retention time increases depending on the membrane used. The antibacterial activity of the filtrated samples is lower than the native protein and decreases with the increase of the applied pressure reaching 55-60% loss for 12 bar which has not been reported in the literature before. The observed results by SEC-HPLC and bacteriological tests, suggest that the conformation of the filtrated molecules are indeed modified. These results highlight the relationship between protein conformation or activity and the imposed shear stress.

Indexed as

Membranes, ArtificialAnti-Bacterial AgentsMuramidasePressureUltrafiltrationAnti-Bacterial AgentsMembranes, ArtificialMuramidase

Identifiers

PMID34103632
PMCPMC8187345
OpenAlexW3146519385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.